Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced a forthcoming Board of Directors meeting scheduled for November 5, 2024, to review the company’s unaudited financial results for the quarter and half-year ending September 30, 2024. Additionally, a trading window closure from September 24 to November 7, 2024, has been communicated, in compliance with insider trading regulations.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
